Kyle M. Hatten

Dr. Kyle M. Hatten is an Associate Professor in the Department of Otorhinolaryngology-Head & Neck Surgery at the University of Maryland School of Medicine. He serves as the Director of Head & Neck Robotic Surgery and Director of the Multi-Disciplinary Head & Neck Cancer Program at the University of Maryland Greenebaum Comprehensive Cancer Center. His clinical expertise spans the surgical management of malignant and benign head and neck tumors, microvascular reconstruction, and robotic surgery.

• Education: University of Virginia (B.A., Economics, 2006), University of Maryland School of Medicine (MD, 2010)
• Training: Residency at University of Pennsylvania (2015), Fellowship in Head & Neck Oncology and Robotic Surgery (2016)

Dr. Hatten’s research focuses on head and neck clinical trials, HPV-associated oropharyngeal cancer, and quality of life outcomes post-surgery. His recent publications highlight advancements in transoral robotic surgery (TORS), proton therapy for recurrent cancer, and genomic analyses of tumor resistance mechanisms.

He is a board-certified Otorhinolaryngologist and Fellow of the American Head & Neck Society, recognized as a Top Doctor by Baltimore Magazine in 2019. His work bridges surgical innovation, multidisciplinary care, and precision oncology, particularly in HPV-related cancers.

• Scientific Awards: Baltimore Magazine Top Doctor (2019)

Dr. Hatten leads clinical trials like the SAVER study for nodal sparing in p16-positive cancers and collaborates on genomic research to improve re-irradiation strategies. His leadership roles emphasize integrating robotic surgery and multidisciplinary approaches to optimize patient outcomes.